What is Glycogen Storage Disease (GSD)?
- Inborn errors of glycogen metabolism that result from pathogenic variants in genes for the proteins involved in glycogen synthesis, degradation, or regulation.
- Glycogen is most abundant in the liver and muscle, which are most affected by these disorders.
- Liver: glycogen is the main source of energy, especially in muscle.
- The main manifestations of GSDs are muscle crumps, exercise intolerance and easy fatigability, and progressive weakness.
Type | Alternative names/subtypes | Affected enzyme | Gene/location | Inheritance | Organ | Frequency | Signs | OMIM |
0 | 0a | Liver glycogen synthase | GYS2 12p12.1 | AR | Liver | Unknown (rare) | Hypoglycemia Morning fatigue Ketosis Convulsion Variable signs and symptoms No hepatomegaly | 240600 |
0b | Muscle glycogen synthase | GYS1 19q13.33 | AR | Muscle (Lack of glycogen in muscle) | Unknown (rare) | Exercise intolerance Hypertrophic cardiomyopathy Fainting | 611556 | |
I | Ia; von Gierke | Glucose-6-phosphate | G6PC 17q21 | AR | Liver, Kidney Intestine | 1/125,000 | Hypoglycemia Lactic acidosis Hyperuricemia Hyperlipidemia Hepatomegaly (abdominal distension) Osteoporosis Kidney disease Hypoglycemic seizures and related changes Hepatic adenomas and carcinoma Endocrine disorders Short stature Pulmonary hypertension-heart failure Anemia | 232200 |
Ib; von Gierke | Glucose-6-phosphate transporter | SLC37A4 11q23 | AR | Liver, Kidney Intestine Neutrophil | 1/500,000 | Same as Type Ia with Neutropenia (recurrent infections) Inflammatory bowel disease Dental diseases | 232200 | |
II | Pompe | Acid α-glucosidase (lysosomal enzyme) – it is also lysosomal storage disease! | GAA | AR | Muscle Heart | 1/40,000 | Myopathy, hypotonia/muscle weakness, hepatomegaly, hypertrophic cardiomyopathy | 232220 |
III | Cori/Forbes | Glycogen debranching enzyme | AGL | Liver, Muscle Heart | 1/100,000 | Hypoglycemia, ketosis, hepatomegaly, myopathy, cirrhosis | 232400 | |
IV | Anderson | Glycogen branching enzyme | GBE1 | Heart Liver | 1/600,000 | Hepatomegaly, liver dysfunction/cirrhosis, myopathy, rare neuromuscular (fetal akinesia, azonal neuropathy, adult polyglucosan body disease) | 232500 | |
V | McArdle | Muscle glycogen phosphorylase | PYGM | Muscle | Fatigue, myoglobinuria, rhabdomyolysis | 232600 | ||
VI | Hers | Liver glycogen phosphorylase | PYGL | Liver | Hepatomegaly, mild hypoglycemia | 232700 | ||
VII | Tarui | Muscle phosphofructose kinase | PFKM | Muscle | Fatigue, myoglobinuria, rhabdomyolysis | 232800 | ||
IX | IXa | Phosphorylase kinase (α2 subunit) | PHKA2 | Hepatomegaly Mild hypoglycemia Fatigability Exercise intolerance | 306000 | |||
IXb | Phosphorylase kinase (β subunit) | PHKB | 261750 | |||||
IXc | Phosphorylase kinase (γ subunit) | PHKG2 | 613027 | |||||
IXd | Phosphorylase kinase (α1 subunit) | PHKA1 | 300559 | |||||
X | – | Muscle phosphoglycerate mutase | PGAM2 | Fatigability Myoglobinuria Exercise intolerance Rhabdomyolysis | 261670 | |||
XI | Fanconi-Bickel | Glucose transporter 2 | SLC2A2 | 227810 | ||||
XII | – | Aldolase A | ALDOA | 611881 | ||||
– | β-Enolase | ENO3 | 612932 | |||||
– | Glycogenin-1 | GYG1 | 603942 | |||||
Danon disease (GSD IIb) | Lysosomal-associated membrane protein 2 | LAMP2 | Muscle Heart | Hypotonia hypertrophic cardiomyopathy rhabdomyolysis | 300257 | |||
Lafora disease | 2A | Laforin | EPM2A | 254780 | ||||
Lafora | 2B | Malin | NHLRC1 | 245780 |